NRG R1216

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Head and Neck

Status:

New, Open

Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck

NCT#01810913